Presented by
Falconbury
A two-day practical and interactive seminar focusing on current contract drafting, negotiating, best practice and related issues within the pharmaceutical, biotech and life sciences sectors.
★★★★★ "All presentations were nicely structured and have provided clear and understandable insights into in... more"
22-23 November 2023
+ 13-14 March 2024, 8-9 July 2024, 20-21 November 2024
from £999
In such a highly regulated industry and in these turbulent and uncertain times, understanding the key challenges of negotiating and drafting an effective and watertight contract on an international level are complex topics. They can be difficult for even the most well-equipped in-house lawyer and most often it is not the lawyer in the driving seat.
Commercial managers from all areas of the pharmaceutical industry are leading negotiations and drafting and managing key contracts on a daily basis. It is vital that both legal counsel and commercial executives not only have the key skills and tactics to create a win:win scenario but also the knowledge to ensure any agreement is within current laws and regulations. The alternative is the exposure of the organisation to unnecessary risk and costly disputes.
The programme will:
The delivery style
This unique and highly interactive two-day programme looks at all stages of the contracting process and aims to deliver applied training through a balanced blend of practical learning. The presenters will use a mixture of practical exercises and case from the pharmaceutical industry to ensure you leave the seminar with the knowledge and skills to perfect all stages of the contracting process.
This training course is part of our Commercial Contracts Training Course collection which has been designed for the in-house lawyer.
By attending this seminar, you will:
Niels Ersbøll, Partner, Arnold & Porter LLP, advises clients on EU competition law in relation to cartels and restrictive practices, merger control, abuse of dominance and State aid. He is currently involved in several pending EU cartel investigations. He advises on merger control investigations by the European Commission and competition authorities worldwide for clients such as General Electric, Boston Scientific, Pfizer, and Sanyo. Where investigations (mergers or cartels) are run by several authorities in parallel, he assists with overall strategy and coordination. Niels also has significant experience helping clients with designing and implementing compliance measures and conducting internal investigations and audits.
Stephen Reese is a partner at Clifford Chance and advises clients on both contentious and non-contentious intellectual property matters including patents, trade marks, trade secrets and copyright. Stephen represents and advises a broad range of clients in relation to the protection, exploitation and enforcement of their intellectual property rights. With significant experience representing clients within the life sciences and technology fields, Stephen has acted on some of the most significant licensing transactions in the life sciences industry. Since 2010, Stephen has been listed as one of IAM’s Top 250 Patent Licensing specialists.
Mario Subramaniam is a Legal Director in the Life Sciences Transactions team at Pinsent Masons. As a former research scientist, he has a passion for the life sciences and has expertise in advising clients on intellectual property, commercial and regulatory aspects of the pharma, biotech, medtech and digital health sectors. He has advised on agreements that span the product life cycle, including strategic licensing and research collaboration arrangements, clinical trials, manufacturing, supply and distribution agreements. Having previously been in-house counsel at a number of prominent life science companies, Mario has a deep understanding of clients’ needs in this sector and is renowned for his clear and practical advice.
Ben Thomas is a Managing Associate at Simmons & Simmons. He has experience of working across a range of contentious and non-contentious intellectual property matters, with a focus on patent and supplementary protection certificate litigation. Assisted by his strong technical background in biochemistry, Ben has a particular interest in the life sciences sector. He has acted for clients in a wide variety of industries, including pharmaceuticals, vaccines and medical devices, TMT and consumer goods (e.g. laundry detergents, vaping devices). He has acted for clients in disputes before the English Patents Court, the UK and European Union Intellectual Property Offices, and the General Court and Court of Justice of the European Union.
James Agnew is a supervising associate at Simmons & Simmons. He has worked on a range of contentious and non-contentious intellectual property matters including commercial licensing, collaboration agreements, software protection, settlement proceedings and the intellectual property aspects of corporate transactions, financings and commercial arrangements. James also advises on life sciences regulatory issues including the promotion of medicines and devices and interactions with healthcare professionals. He has experience in a wide range of industries, including life sciences, TMT, finance, Fintech, energy and defence, with a focus on transactions involving intellectual property.
Tom Carver is a partner at White & Black Legal. He has broad experience in patent litigation (infringement and validity) in pharmaceuticals, medical and mechanical devices and electronics, including advice concerning threats provisions. Tom co-ordinates and manages litigation in multiple jurisdictions, and has particular expertise in biotech patent litigation. Tom has a degree in genetics and worked on the first patent case in the UK relating to genetically modified organisms, Monsanto v Cargill, and the first patent case in the UK on DNA sequences, Eli Lilly v Human Genome Sciences. He has been involved in some of the most significant patent cases in the UK in recent years. Tom lived in China for three years, where he managed intellectual property enforcement for Western clients, including Dyson. His experience includes patent (design, utility and invention), trade secret, trade mark and copyright litigation against companies in provinces across China in sectors including capital and consumer goods, cosmetics and medical devices. He also has experience of non-judicial IPR enforcement in China at trade fairs, online and by Customs seizures.
Fred Nicolle is a UK and European qualified patent attorney (CPA, EPA) at Simmons & Simmons. He has over 15 years experience specialising in patent prosecution and contentious matters for the life sciences sector. He has particular expertise in pharmaceuticals, medical devices, consumer health products, cosmetics, foods and health supplements. He graduated from the University of Cambridge with a Master of Natural Sciences degree with a final year research project in synthetic organic chemistry.
Fred has extensive experience of contentious patent proceedings in opposition at the European Patent Office and in national litigation, having defended patents for numerous commercially important products. Notable examples include the defence of patents for Noctiva™ (desmopressin acetate nasal spray), Bendeka® (bendamustine HCl injection), Revlimid® (lenalidomide), Xeplion®/Invega Sustenna® (paliperidone palmitate), wound dressings, and contact lenses.
Fred is featured in The Legal 500 and IAM Patent 1000 as a recommended patent attorney.
Richard Brady is a lawyer who has spent many years working in Europe and the Middle East in the legal, financial and insurance arenas. He has a degree from Cambridge College of Teachers (2005) on Teaching English and founded the British Legal Centre in 2010. He has taught professional legal skills in many companies around the World, including Deloitte and Touche, EY, White & Case, Baker McKenzie, Shalakany Law Office, DLA Piper and Clifford Chance. He has also conducted live training courses at legal departments of corporations, including: Shell Oil, Master Foods, Air Liquide, DAMAC (Dubai), ENKA (Turkey) EMBRACO/Whirlpool (Brazil), and Mowasalat (Qatar).
His specialist areas include contract law, contract drafting, M&A in the pharma industry, arbitration law and FIDIC contracts.
NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:
Please contact us for pricing if you are interested in booking 5 or more delegates
22-23 November 2023
Live online
09:30-17:30 UK (London) (UTC+00)
10:30-18:30 Paris (UTC+01)
04:30-12:30 New York (UTC-05)
Course code 12690
Until 18 Oct
Not ready to book yet?
for 7 days, no obligation
13-14 March 2024
Live online
09:30-17:30 UK (London) (UTC+00)
10:30-18:30 Paris (UTC+01)
05:30-13:30 New York (UTC-04)
Course code 13520
Until 07 Feb
Not ready to book yet?
for 7 days, no obligation
8-9 July 2024
Classroom
Rembrandt Hotel
London
09:00-17:00 UK (London)
Course code 13782
Optional £275/€395/$450 per night
Until 03 Jun
Not ready to book yet?
for 7 days, no obligation
20-21 November 2024
Live online
09:30-17:30 UK (London) (UTC+00)
10:30-18:30 Paris (UTC+01)
04:30-12:30 New York (UTC-05)
Course code 14039
Until 16 Oct
Not ready to book yet?
for 7 days, no obligation
* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price.
All presentations were nicely structured and have provided clear and understandable insights into individual issues in the pharmaceutical industry. Very pleasant environment and very high quality speakers.
Jul 10 2023
Patricia Baratova
Legal Counsel , Sun Pharmaceutical Industries (Europe) B.V.
Nov 23 2022
Excellent webinar, I would (and did) highly recommend it. Large variety of subjects with much useful insights and information. The different speakers make it more dynamic and they were all very open to discussion and/or taking questions.
Juliette Gordeau
Legal Counsel, TRB Chemedica International S.A.
Nov 24 2021
I found the webinar very informative and helpful. The speakers were very clear and practice-oriented.
Maria João Rodrigues
Legal Counsel, BIAL - Portela & Companhia SA
Nov 24 2021
Overall it was very good
Cristina Bertulli
Director of Business Development and Operations , Exactmer Ltd
Nov 19 2019
This course was brilliant and covered all the key points. The speakers were highly knowledgeable and had practical insights and fresh perspectives on drafting issues and implications. Having multiple speakers allowed for a fresh and dynamic course, and increased the amount of information absorbed.
James Langston
Contracts Manager, AstraZeneca
Nov 19 2019
Good overview of content, great organisation.
Amish Unka
Legal Counsel, Morningside Healthcare Limited
Jun 5 2019
High quality content and course materials. Professional presentation within a relaxed learning environment. Fantastic speakers who were happy to answer questions during their talks and the breaks.
Grace Hamlett
Legal Counsel, Mereo BioPharma
Nov 20 2018
Insightful teachers, great take-home material, stupendous learning environment.
Luis Briseno Roa
Associate Director, Alexion R&D France
Nov 20 2018
A fantastic program and great speakers/participants.
Mia Rensch-Jacobsen
Business Operations Manager, Roche Innovation Center Copenhagen
Jun 6 2018
All speakers are excellent and experts in their fields – I really enjoyed listening to them. The course is very extensive covering a wide variety of topics.
Avadhanula Yagna Praveen Kumar
Head of Intellectual Property Management, Pharmaniaga Berhad
Nov 20 2018
Very useful course for my future career.
Christopher France
Business Development Associate, GSK Vaccines Srl
Nov 20 2018
Great and useful course.
Taisier Adil
Legal Counsel, Xendo Holding B.V. – A ProPharma Group Company
Jun 6 2018
Good topics and speakers.
Wan Intan Idura Wan Ismail
Deputy Director, PHARMANIAGA BERHAD
Jun 6 2018
Excellent and immediately useful.
Dan Hudson
Manager, GSK Vaccines SRL
Jun 6 2018
I particularly liked the quality of the speakers and the various workshops.
Zian Bertrand
In-House Counsel , ERYTECH PHARMA
Nov 20 2017
I think that overall the course material was comprehensive and touched on a lot of different topics. I would recommend this course.
Angele Azzopardi
In House Legal Counsel , Starpharma Malta
Nov 20 2017
Very good course and good presentations/topics.
Ilaria Pastorello
Manager Vaccines Business Development, GSK Biologicals SA
Nov 20 2017
The content was very good and I appreciated the booklet provided. I found ... the speakers very engaging and everything was well organised and well presented.
Leah Baker
Pharmacovigilance Scientist, Norgine Ltd
Nov 20 2017
I found the course very practical and engaging
Tania Damianova
Company Lawyer, UCB S.A.
Jun 7 2017
The content is excellent. The speakers are highly qualified and talented in terms of lecturing.
Moataz Mahmoud
Legal & Compliance Advisor, EBN Sina Medical Establishment
Nov 20 2017
Very informative, very knowledgeable speakers, content good.
Luciana Schwambach
Contract Manufacturing Business Development Director, Xellia Pharmaceuticals ApS
Nov 20 2017
Very knowledgeable experts.
Olivia Chalwin
Major Contracts Manager, University of Southampton
Jun 7 2017
Very good, good alignment with professional practice.
Erik Popping
Corporate & Legal Counsel, Intravacc
Nov 23 2016
Great material and speakers
Paraskevi Sakallaridi
Lawyer, ELPEN Pharmaceutical Co. Inc.
Nov 23 2016
Good overall impression. Certain topics remained at introductory level without going into depth
Lina Yaneva
Legal Counsel, Mylan SAS
Jun 8 2016
The course was well organised. Unfortunately patent issues were skimmed over
Jeremy Whitman
Legal Department, Sterling S.p.A.
Nov 23 2016
Very interesting topics
Khady Seck
Mylan S.A.S.
Nov 18 2015
Very well organised, really enjoyed the higher energy speakers as I find it difficult to sit through three days if the speakers are low energy
Darragh O'Dea
Legal Counsel, BioMarin Pharmaceutical
Nov 18 2015
The course was good. I would suggest more practical examples.
Elda Selfo
Site Contract Specialist , INC Research
Nov 18 2015
Overall good. The seminar room with no windows and fresh air was the only negative.
Kristina Anna Reitmeier
European PharmInvent Services, s.r.o.
Jun 2 2015
Very professional. Some of the speaker were too fast, but all of them very friendly and kind.
Roberto Aldovini
Legal Counsel, APR Applied Pharma Research s.a
Jun 2 2015
Enough but not very deep
Eva Rosal Negre
Legal Advisor , Laboratories Hipra, S.A
Jun 2 2015
Organisations are paying a considerable amount for their employees to attend this course and the speakers should therefore deliver better presentations. The good speakers were engaging, interested in feedback and seemed to care. Given the professional level of the speakers the lack of professionalism in the way that they presented their subject in the time available was surprising.
Rachel Simpson
Contracts Manager, University of Dundee
Nov 18 2015
Days 1-2 were very detailed, although some presenters did not encourage interaction
Neil Thompson
Supply Chain Manager, Suir Pharma Ireland
Nov 19 2014
Generally high quality speakers. Good all-round refresher and networking opportunity.
Nick Plummer
Senior Director, EU Legal Services , Patheon UK Ltd
Nov 19 2014
The content was really interesting and useful, was communicated effectively and all the presenters were good. The negotiation part was great!
Eleni Pentafragka
ELPEN S.A.
Nov 19 2014
Very helpful for practising in-house lawyers courses. The negotiation strategies workshop should have been adapted to lawyers.
Maria Ganeva
Contracts Manager, Genzyme
Nov 19 2014
Speakers were fine and knew the subject well but some presentations were superficial
Maria Teresa Vazquez Calo
Lawyer, Assesora estudio jurídico y tributario S.L.P
Nov 19 2014
More case studies would be better
Jan Smidrkal
Tech Transfer Manager, Institute of Chemical Technology Prague
Jun 3 2014
Very good course, but many details covered in a short time.
Christopher Lambert
Chief Legal Officer, Fertin Pharma A/S
Nov 18 2013
The course was excellent, very useful and well organized.
Borislav Dakic
Director of Legal Department, Hemofarm AD
Nov 18 2013
Really excellent including Susan Sungleton
Patricia Hoyle
Global Head Intellectual Property, Evolva Holding SA
Jun 5 2013
Speakers were well prepared and had good presentation skills. I enjoyed the course.
Dragan Lutz
SENIOR LICENSING MANAGER, JADRAN-GALENSKI LABORATORIJ d.d.
Nov 18 2013
Content was useful, but I would recommend a bit more focus on generics as well. All speakers were competent and presented well.
Milica Milekic
Senior Legal Counsel, HEMOFARM AD
Jun 5 2013
Lots of content, some very good presentations and speakers.
Rebecca Flory
Solicitor, Edinburgh Research & Innovation Ltd
Nov 12 2012
Very relevant and useful to the topic of drafting commercial agreements in the pharma industry
Asif Altaf
Allergan Ltd
Nov 12 2012
Very helpful and detailed material, good coverage of all pharma legal issues considering time available.
Roberta Comerro
Ginsana SA
Nov 12 2012
Given the various topics being covered in a span of 3 days I think the speaker couldn't have done better
Sangeeta Shah
Mercury Pharma
United Kingdom
Switzerland
Germany
Denmark
France
Spain
Belgium
Netherlands
Italy
Austria
Ireland
Greece
United States of America
Czech Republic
Portugal
Russia
Sweden
Norway
Poland
Ukraine
Croatia
Finland
Korea, Republic Of
Latvia
Romania
Serbia
Turkey
Brazil
Bulgaria
Canada
Colombia
Cyprus
Hungary
Jordan
Luxembourg
Malaysia
Malta
Morocco
Qatar
Slovenia
United Arab Emirates
3 days
Typical duration
Pricing from:
We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.
Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:
Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to: